Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price rises 2.32% to Rs 1,995

Published: 17 September 2026 at 9:48:30 AM IST

SUMMARY: Ipca Laboratories Share Price rose to Rs 1,995, up 2.32% from the previous close, with market capitalisation at Rs 49,074.01 Cr.

Ipca Laboratories Share Price is in focus today after the stock rose 2.32% to Rs 1,995 from the previous close of Rs 1,949.85. The move added Rs 45.15 to the day’s gain and took market capitalisation to Rs 49,074.01 Cr. Today’s open was Rs 1,955.85, the day’s low was Rs 1,955.2 and the stock touched Rs 1,995, which also stands as the day’s high. The turnover was Rs 1.08 Cr. The supplied data confirms the price event, while a company-specific catalyst is not established in the dataset.

For readers tracking Ipca Laboratories Share Price Today, the key takeaway is straightforward: the stock is trading above the previous close with a modest intraday range and a clear same-day price rise. In Univest coverage, Ipca Laboratories Stock News is therefore relevant not because of a stated trigger, but because the verified numbers show an active move in the share price, market cap and valuation profile. Investors following Ipca Laboratories Share Price can read the move alongside fundamentals, sector benchmarks and peer comparisons rather than relying on speculation.

Ipca Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,995
Previous Close	Rs 1,949.85
Today's Move	Rs 45.15 (+2.32%)
Open	Rs 1,955.85
High	Rs 1,995
Low	Rs 1,955.2
Turnover	Rs 1.08 crore
Market Capitalisation	Rs 49,074.01 crore
Market Cap Category	Large Cap

Ipca Laboratories Ltd. (IPCALAB) rose to Rs 1,995 from the previous close of Rs 1,949.85, a move of Rs 45.15 or 2.32%. The stock opened at Rs 1,955.85, reached a high of Rs 1,995, recorded a low of Rs 1,955.2.

Ipca Laboratories Share Price Today shows a rise from Rs 1,949.85 to Rs 1,995, a gain of Rs 45.15 or 2.32%. The stock opened at Rs 1,955.85, moved between Rs 1,955.2 and Rs 1,995, and finished at the day’s high. Turnover stood at Rs 1.08 Cr. This is the verified price action behind the day’s stock news.

Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 49,074.01 crore
P/E Ratio	37.77x
P/B Ratio	5.83x
ROE	15.88%
ROCE	19.41%
EPS	Rs 51.63
Book Value Per Share	Rs 334.38
Dividend Yield	0.31%

Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 37.77x, P/B 5.83x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.

Ipca Laboratories Ltd. has a market capitalisation of Rs 49074.01 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.77x, P/B at 5.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	37.77x
Benchmark Median P/E	31.35x
Benchmark Average P/E	47.81x
Benchmark P/E Range	3.45x to 661.74x
Company P/B Ratio	5.83x
Benchmark Median P/B	2.98x
Company ROE	15.88%
Benchmark Median ROE	11.78%
Company ROCE	19.41%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 49,074.01 crore
Benchmark Median Market Cap	Rs 735.67 crore

Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.77x, which is above the benchmark median of 31.35x, a difference of +20.48%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.78%, a difference of +34.8%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.65%, a difference of +42.2%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,277.97	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,43,965.63	83.5	13.83	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.11	20.44	26.76	19.27
Cipla Ltd.	CIPLA	1,09,949.53	32.59	3.12	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,625.67	24.42	4.09	19.69	21.39

Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.77x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 49,074.01 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Ipca Laboratories

• Ipca Laboratories Share Price rose 2.32% today to Rs 1,995, after closing the previous session at Rs 1,949.85.
• The day’s range was Rs 1,955.2 to Rs 1,995, with the stock opening at Rs 1,955.85 and finishing at the day’s high.
• Market capitalisation stands at Rs 49,074.01 Cr, which is far above the industry median market cap in the supplied benchmark.
• The company’s P/E of 37.77 and P/B of 5.83 are above the sector median values of 31.35 and 2.98, respectively.
• ROE of 15.88 and ROCE of 19.41 are both above the industry median, while EPS is Rs 51.63 and book value is Rs 334.38.

About Ipca Laboratories

Ipca Laboratories Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not describe revenue mix or business segments, so the company profile can only be stated at the industry level from the verified dataset. Even so, the market is clearly treating it as a significant healthcare name, with a market capitalisation of Rs 49,074.01 Cr and a share price of Rs 1,995. On the financial side, the supplied ratios show earnings per share of Rs 51.63, book value of Rs 334.38 and a dividend yield of 0.31%, which together provide a simple snapshot of the company’s earnings and accounting base behind the current Ipca Laboratories Share Price. For readers comparing Ipca Laboratories Stock News with other healthcare names, the company’s presence in Pharmaceuticals & Drugs and its above-median profitability ratios are the main verified points available in this dataset. That makes the stock relevant for investors following India’s healthcare universe through Univest.

Track Ipca Laboratories Share Price on Univest

Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Ipca Laboratories Share Price on Univest for live share price updates, financial ratios, shareholding pattern, market insights, 52-week levels and company news. Univest also helps readers compare Ipca Laboratories Share Price Today with sector and peer data in one place.

Frequently Asked Questions

Why is Ipca Laboratories Share Price rising today?

Ans. Ipca Laboratories Share Price rose 2.32% to Rs 1,995 today, but the dataset does not establish a company-specific catalyst. The verified data confirms the move through the day’s open, high, low, previous close and turnover.

What is Ipca Laboratories Share Price today?

Ans. Ipca Laboratories Share Price today is Rs 1,995. It moved up from Rs 1,949.85 in the previous session, adding Rs 45.15. The stock also closed at the day’s high in the supplied data.

How much did Ipca Laboratories Share Price rise?

Ans. Ipca Laboratories Share Price rose by Rs 45.15, which equals 2.32% for the day. The move came after an opening price of Rs 1,955.85 and an intraday range between Rs 1,955.2 and Rs 1,995.

What is Ipca Laboratories market capitalisation?

Ans. Ipca Laboratories has a market capitalisation of Rs 49,074.01 Cr. In the supplied sector benchmark, that is well above the industry median market cap of Rs 735.67 Cr and above the sector average of Rs 13,941.93 Cr.

How does Ipca Laboratories compare on valuation?

Ans. Ipca Laboratories trades at a P/E of 37.77 and P/B of 5.83. Both are above the sector median values of 31.35 and 2.98, while ROE of 15.88 and ROCE of 19.41 are also above sector medians.

How does Ipca Laboratories compare with peers?

Ans. Ipca Laboratories sits above Cipla and Zydus on P/E, while still below Divi’s Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are stronger than some peers, though Lupin shows higher profitability ratios in the supplied peer set.

What do EPS, book value and dividend yield show for Ipca Laboratories?

Ans. EPS is Rs 51.63, book value is Rs 334.38 and dividend yield is 0.31%. These figures help readers understand earnings per share, accounting net worth per share and the historical payout context behind Ipca Laboratories Share Price.

Where can I track Ipca Laboratories Share Price on Univest?

Ans. Univest tracks Ipca Laboratories Share Price with live updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. It also helps compare the stock with sector benchmarks and supplied peer data in a simple format.